Medical Congress News

Medical Digest & Congress Report

Health EN ↓ Epizody: 770

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Určitě navštivte web podcastu a podpořte jeho tvůrce: medicaldigest.org

Autor

Medical Congress News

Kategorie

Health

Web podcastu

medicaldigest.org

Nejnovější epizoda

17. říj 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials - report from ASH 2025 07.01.2026 6:06

Jesse Tettero discusses the results from the HARMONY Alliance study at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:validation-measurable-residual-disease-surrogate-endpoint-acute-myeloid-leukemia-harmony-alliance-study-european-randomized-trials

Symptom-based progression-free survival as a clinically relevant and patient-centric endpoint in chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the ALPINE trial 07.01.2026 2:55

Jennifer R. Brown explains the results from the ALPINE trial at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:symptom-based-progression-free-survival-clinically-relevant-and-patient-centric-endpoint-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-results-alpine-trial

Azacitidine–Venetoclax Combination Outperforms Standard Care in Acute Myeloid Leukemia Patients Eligible for Intensive Chemotherapy - report from ASH 2025 07.01.2026 6:18

Amir Fathi discusses the results from a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:azacitidinevenetoclax-combination-outperforms-standard-care...

What's new in myeloma? - report from ASH 2025 07.01.2026 3:09

Enrique Ocio discusses what's new in multiple myeloma treatement at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:whats-new-myeloma

Novelties in Acute Myeloid Leukemia at ASH2025 07.01.2026 4:28

Mark Levis discusses the novelties in acute myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-acute-myeloid-leukemia-ash2025

State of the art treatment of Chronic Myeloid Leukemia - report from ASH 2025 18.12.2025 5:43

Michael J. Mauro discusses the state of the art treatment of chronic myeloid leukemia at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-chronic-myeloid-leukemia

Myelodysplastic Syndrome Highlights from ASH 2025 18.12.2025 5:15

Mikkael A. Sekeres discusses the state of the art treatment in myelodysplastic syndrome at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:myelodysplastic-syndrome-highlights-ash-2025

COBRA trial and other novelties in multiple myeloma at ASH 2025 18.12.2025 16:04

Andrzej Jakubowiak discusses the COBRA trial and other novelties in multiple myeloma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:cobra-trial-and-other-novelties-multiple-myeloma-ash-2025

Multiple Myeloma Highlights from ASH 2025 18.12.2025 9:10

Paul G Richardson discusses multiple myeloma highlights at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:multiple-myeloma-highlights-ash-2025

Diagnosis and Management of Cold Agglutinin Disease - report from ASH 2025 18.12.2025 13:20

Sigbjorn Berentsen discusses the diagnosis and management of cold agglutinin disease at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:diagnosis-and-management-cold-agglutinin-disease

Breakthrough in the treatement of Multiple Myeloma - report from ASH 2025 18.12.2025 11:20

Xavier Leleu explains the breakthrough in the treatement of multiple myeloma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:breakthrough-treatement-multiple-myeloma

Novelties in Diffuse Large B-cell Lymphoma at ASH2025 18.12.2025 6:08

Joshua Brody discusses the novelties in diffuse large B-cell lymphoma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-diffuse-large-b-cell-lymphoma-ash2025

First-of-Its-Kind Phase 3 Trial Shows Pirtobrutinib Is Noninferior to Ibrutinib in Treatment-Naïve CLL - report from ASH 2025 17.12.2025 6:53

Wojciech Jurczak discusses the results from the global, randomized BRUIN CLL-313 study presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:first-its-kind-phase-3-trial-shows-pirtobrutinib-noninferior-ibrutinib-treatment-naive-cll

New findings support a chemo-free approach for treating Ph+ ALL - report from ASH 2025 17.12.2025 8:37

Sabina Chiaretti discusses the results of the phase 3 GIMEMA ALL2820 study at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:new-findings-support-chemo-free-approach-treating-ph-all

Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia - report from ASH 2025 17.12.2025 6:07

Hanny Al-Samkari discusses the results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia who failed first-line corticosteroid treatment at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novel-agent-ianalum...

Bispecific Combo May Offer “Functional Cure” in Multiple Myeloma - report from ASH 2025 17.12.2025 8:52

María-Victoria Mateos discusses the results of a phase 3 study of teclistamab plus daratumumab for relapsed refractory multiple myeloma presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:bispecific-combo-may-offer-functional-cure-multiple-myeloma

Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma - report from ASH 2025 17.12.2025 5:02

Lorenzo Falchi discusses the results of phase 3 EPCORE FL-1 trial presented at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:epcoritamab-combo-significantly-improves-efficacy-2l-rr-follicular-lymphoma

Novelties in Follicular Lymphoma at ASH2025 17.12.2025 6:35

Joshua Brody discusses the novelties in follicular lymphoma at the American Society of Hematology's 67th Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:novelties-follicular-lymphoma-ash2025

Remote BP Monitoring and Drug Titration – Does it work? How do we do it? - report from AHA 2025 03.12.2025 13:03

Professor Beverly B. Green shares her insights on remote BP monitoring and drug titrationat after the AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:remote-bp-monitoring-and-drug-titration-does-it-work-how-do-we-do-it

Effectiveness of High-Dose vs. Standard-Dose Inactivated Influenza Vaccine in Individuals with and without Atherosclerotic Cardiovascular Disease: A Pooled FLUNITY-HD Trial Analysis 03.12.2025 9:30

Professor Manan Pareek shares his insights on the results from the FLUNITY-HD trial analysis at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:effectiveness-high-dose-vs-standard-dose-inactivated-influenza-vaccine-individuals-and-without-atherosclerotic-cardiovascular-disease-pooled-flunity-hd-trial-analysis

Blood Pressure and Symptomatic Hypotension with Dapagliflozin vs. Placebo in Patients Hospitalized with Heart Failure - report from AHA 2025 03.12.2025 3:02

Professor Siddharth M. Patel shares his insights on the results from the DAPA ACT HF-TIMI 68 trial at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:blood-pressure-and-symptomatic-hypotension-dapagliflozin-vs-placebo-patients-hospitalized-heart-failure

DASH-Patterned Groceries Reduce Blood Pressure - report from AHA 2025 03.12.2025 10:03

Professor Stephen P. Juraschek discusses the results from the GoFresh randomized clinical trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:dash-patterned-groceries-reduce-blood-pressure

TUXEDO-2: Ticagrelor vs. Prasugrel in Patients With Diabetes and Multivessel Disease After PCI - report from AHA 2025 03.12.2025 6:36

Professor Sripal Bangalore discusses the findings from the TUXEDO-2 trial presented at at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:tuxedo-2-ticagrelor-vs-prasugrel-patients-diabetes-and-multivessel-disease-after-pci

Aldosterone and Mineralocorticoid Receptors: New Paradigms and Novel Therapies - report from AHA 2025 03.12.2025 9:04

Professor John M. Flack shares his insights on the new paradigms and novel therapies in aldosterone and mineralocorticoid receptors at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:aldosterone-and-mineralocorticoid-receptors-new-paradigms-and-novel-therapies

Navigating AHA Scientific Statements: Advancing Evidence-Based Cardiovascular Care - report from AHA 2025 03.12.2025 9:50

Professor Bradley S. Marino shares his insights on the advancing evidence-based cardiovascular care at AHA Scientific Sessions 2025. Video: https://medicaldigest.org/scientific-contents/interview:navigating-aha-scientific-statements-advancing-evidence-based-cardiovascular-care